136 related articles for article (PubMed ID: 29323055)
1. Immunohistochemical and molecular markers in urothelial carcinoma.
Agrawal R
Indian J Pathol Microbiol; 2017; 60(4):462-463. PubMed ID: 29323055
[No Abstract] [Full Text] [Related]
2. Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.
Amara N; Palapattu GS; Schrage M; Gu Z; Thomas GV; Dorey F; Said J; Reiter RE
Cancer Res; 2001 Jun; 61(12):4660-5. PubMed ID: 11406532
[TBL] [Abstract][Full Text] [Related]
3. Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma.
Weyerer V; Weisser R; Moskalev EA; Haller F; Stoehr R; Eckstein M; Zinnall U; Gaisa NT; Compérat E; Perren A; Keck B; Allory Y; Kristiansen G; Wullich B; Agaimy A; Hartmann A; Bertz S
Histopathology; 2019 Dec; 75(6):865-875. PubMed ID: 31348552
[TBL] [Abstract][Full Text] [Related]
4. [Interdisciplinary networking for clinical and molecular questions in non-muscle invasive urothelial carcinoma of the bladder].
Denzinger S; Hartmann A; Hofstaedter F; Knuechel R; Wild PJ; Zaak D; Stief C; Wieland WF; Stoehr R; Burger M
Urologe A; 2007 Sep; 46(9):1126-8. PubMed ID: 17634910
[No Abstract] [Full Text] [Related]
5. Editorial comment on: immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue.
Papatsoris A; Deliveliotis C
Eur Urol; 2008 May; 53(5):1073. PubMed ID: 17980953
[No Abstract] [Full Text] [Related]
6. Immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue.
Feil G; Maurer S; Nagele U; Krug J; Bock C; Sievert KD; Stenzl A
Eur Urol; 2008 May; 53(5):1066-72. PubMed ID: 17980954
[TBL] [Abstract][Full Text] [Related]
7. The 2004 WHO classification of bladder tumors: a summary and commentary.
Montironi R; Lopez-Beltran A
Int J Surg Pathol; 2005 Apr; 13(2):143-53. PubMed ID: 15864376
[TBL] [Abstract][Full Text] [Related]
8. An accurate diagnostic approach for urothelial carcinomas based on novel dual methylated DNA markers in small-volume urine.
Wu Y; Cai D; Fan J; Meng C; He S; Li Z; Zhang L; Yang K; Wang A; Li X; Du Y; Xiong S; Xia M; Li T; Dong L; Gong Y; Zhou L; Li X
Chin Med J (Engl); 2024 Jan; 137(2):232-234. PubMed ID: 37455255
[No Abstract] [Full Text] [Related]
9. Chromosomal imbalances in successive moments of human bladder urothelial carcinoma.
Nascimento e Pontes MG; da Silveira SM; Trindade Filho JC; Rogatto SR; Viana de Camargo JL
Urol Oncol; 2013 Aug; 31(6):827-35. PubMed ID: 21763161
[TBL] [Abstract][Full Text] [Related]
10. [So-called "superficial" bladder tumors. Which classification in 2003? Part 2: Flat urothelial lesions].
Sibony M; Billerey C
Ann Pathol; 2003 Feb; 23(1):35-45. PubMed ID: 12743498
[TBL] [Abstract][Full Text] [Related]
11. A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma.
Patschan O; Sjödahl G; Chebil G; Lövgren K; Lauss M; Gudjonsson S; Kollberg P; Eriksson P; Aine M; Månsson W; Fernö M; Liedberg F; Höglund M
Eur Urol; 2015 Nov; 68(5):824-32; discussion 835-6. PubMed ID: 25770486
[TBL] [Abstract][Full Text] [Related]
12. A critical appraisal of the classification of urothelial tumours: time for a review of the evidence and a radical change?
Harnden P
BJU Int; 2007 Apr; 99(4):723-5. PubMed ID: 17155966
[No Abstract] [Full Text] [Related]
13. [Preneoplastic lesions and precursors of urothelial cancer].
Knüchel-Clarke R; Gaisa NT
Pathologe; 2016 Feb; 37(1):33-9. PubMed ID: 26811248
[TBL] [Abstract][Full Text] [Related]
14. Expression pattern of p53-binding protein 1 as a new molecular indicator of genomic instability in bladder urothelial carcinoma.
Matsuda K; Kawasaki T; Akazawa Y; Hasegawa Y; Kondo H; Suzuki K; Iseki M; Nakashima M
Sci Rep; 2018 Oct; 8(1):15477. PubMed ID: 30341375
[TBL] [Abstract][Full Text] [Related]
15. [New information in the classification of urothelial tumors of the bladder].
Guillou L
Ann Pathol; 1999; 19(5 Suppl):S103-7. PubMed ID: 10599468
[No Abstract] [Full Text] [Related]
16. Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.
Kurtis B; Zhuge J; Ojaimi C; Ye F; Cai D; Zhang D; Fallon JT; Zhong M
Ann Diagn Pathol; 2016 Apr; 21():7-11. PubMed ID: 27040924
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity at 9q32-33 (DBC1 locus) in primary non-invasive papillary urothelial neoplasm of low malignant potential and low-grade urothelial carcinoma of the bladder and their associated normal urothelium.
Lopez-Beltran A; Alvarez-Kindelan J; Luque RJ; Blanca A; Quintero A; Montironi R; Cheng L; Gonzalez-Campora R; Requena MJ
J Pathol; 2008 Jul; 215(3):263-72. PubMed ID: 18452128
[TBL] [Abstract][Full Text] [Related]
18. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
[TBL] [Abstract][Full Text] [Related]
19. Toward Optimal Prediction of Prognosis in T1 Urothelial Carcinoma of the Bladder.
van Rhijn BW; Behrendt MA; Hendricksen K; van der Kwast TH
Eur Urol; 2015 Nov; 68(5):833-4;discussion 835-6. PubMed ID: 25813690
[No Abstract] [Full Text] [Related]
20. Bladder cancer redefined.
Murphy WM
Cancer; 1999 Nov; 86(10):1890-2. PubMed ID: 10570409
[No Abstract] [Full Text] [Related]
[Next] [New Search]
